IL291315A - Stable, concentrated radiopharmaceutical composition - Google Patents
Stable, concentrated radiopharmaceutical compositionInfo
- Publication number
- IL291315A IL291315A IL291315A IL29131522A IL291315A IL 291315 A IL291315 A IL 291315A IL 291315 A IL291315 A IL 291315A IL 29131522 A IL29131522 A IL 29131522A IL 291315 A IL291315 A IL 291315A
- Authority
- IL
- Israel
- Prior art keywords
- stable
- radiopharmaceutical preparation
- concentrated
- concentrated radiopharmaceutical
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/121—Solutions, i.e. homogeneous liquid formulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19197607 | 2019-09-16 | ||
| PCT/EP2020/075767 WO2021052960A1 (en) | 2019-09-16 | 2020-09-15 | Stable, concentrated radiopharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL291315A true IL291315A (en) | 2022-05-01 |
Family
ID=67981980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL291315A IL291315A (en) | 2019-09-16 | 2022-03-13 | Stable, concentrated radiopharmaceutical composition |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12685790B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4031193A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7762648B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220063218A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114728088A (cg-RX-API-DMAC7.html) |
| AR (1) | AR119974A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020349002B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3154302A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL291315A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021052960A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250032652A1 (en) * | 2021-11-30 | 2025-01-30 | Nihon Medi-Physics Co., Ltd. | Stabilized radiopharmaceutical composition |
| CN114404618A (zh) * | 2022-03-28 | 2022-04-29 | 北京先通国际医药科技股份有限公司 | 放射性药物水溶液及其用途 |
| CN114404619A (zh) * | 2022-03-28 | 2022-04-29 | 北京先通国际医药科技股份有限公司 | 放射性药物水溶液及其制备方法和用途 |
| CN116920129A (zh) * | 2022-04-02 | 2023-10-24 | 北京先通国际医药科技股份有限公司 | 放射性药物水溶液及其制备方法和用途 |
| EP4661919A1 (en) | 2023-02-08 | 2025-12-17 | Novartis AG | Methods for treating glioblastoma |
| TW202434313A (zh) | 2023-02-23 | 2024-09-01 | 瑞士商諾華公司 | 用於治療乳癌之方法 |
| JPWO2025058000A1 (cg-RX-API-DMAC7.html) | 2023-09-13 | 2025-03-20 | ||
| TW202527951A (zh) | 2023-12-15 | 2025-07-16 | 瑞士商諾華公司 | 用於治療乳腺癌的方法 |
| WO2026149506A1 (zh) * | 2025-01-10 | 2026-07-16 | 天津恒瑞医药有限公司 | 一种药物组合物及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3812680B2 (ja) | 1994-03-16 | 2006-08-23 | マリンクロッド・インコーポレイテッド | 放射性医薬用途のペプチド類およびタンパク質類の安定化 |
| CN100418585C (zh) * | 2003-07-24 | 2008-09-17 | 伯拉考成像股份公司 | 稳定的放射性药物组合物及制备方法 |
| WO2008009444A1 (en) | 2006-07-19 | 2008-01-24 | Van Dulmen, Adrianus, A. | Use of ethanol for stabilizing a single-vial liquid formulation of a radiolabeled peptide |
| KR102190005B1 (ko) | 2012-09-25 | 2020-12-15 | 어드밴스드 액셀러레이터 애플리케이션즈 유에스에이, 인코퍼레이티드. | Grpr-양성 암의 검출, 진단과 치료를 위한 grpr-길항제 |
| US20150217006A1 (en) | 2014-02-06 | 2015-08-06 | Immunomedics, Inc. | Al-f-18-labeled, al-f-19-labeled and ga-68-labeled gastrin-releasing peptide receptor (grpr)-antagonists for imaging of prostate cancer |
| EP3664845A4 (en) | 2017-08-08 | 2021-03-10 | Pionyr Immunotherapeutics, Inc. | COMPOSITIONS AND METHODS OF DEACTIVATION OF MYELOID CELLS EXPRESSING TREM1 |
-
2020
- 2020-09-15 KR KR1020227012069A patent/KR20220063218A/ko active Pending
- 2020-09-15 EP EP20768373.1A patent/EP4031193A1/en active Pending
- 2020-09-15 CA CA3154302A patent/CA3154302A1/en active Pending
- 2020-09-15 US US17/753,762 patent/US12685790B2/en active Active
- 2020-09-15 JP JP2022516404A patent/JP7762648B2/ja active Active
- 2020-09-15 AR ARP200102561A patent/AR119974A1/es unknown
- 2020-09-15 WO PCT/EP2020/075767 patent/WO2021052960A1/en not_active Ceased
- 2020-09-15 AU AU2020349002A patent/AU2020349002B2/en active Active
- 2020-09-15 CN CN202080079709.9A patent/CN114728088A/zh active Pending
-
2022
- 2022-03-13 IL IL291315A patent/IL291315A/en unknown
-
2025
- 2025-06-11 US US19/234,864 patent/US20250332301A1/en active Pending
- 2025-10-20 JP JP2025176508A patent/JP2026031934A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220063218A (ko) | 2022-05-17 |
| CA3154302A1 (en) | 2021-03-25 |
| WO2021052960A1 (en) | 2021-03-25 |
| JP2022548875A (ja) | 2022-11-22 |
| EP4031193A1 (en) | 2022-07-27 |
| AR119974A1 (es) | 2022-01-26 |
| US12685790B2 (en) | 2026-07-21 |
| JP2026031934A (ja) | 2026-02-25 |
| TW202123976A (zh) | 2021-07-01 |
| AU2020349002B2 (en) | 2024-05-02 |
| US20250332301A1 (en) | 2025-10-30 |
| US20220401593A1 (en) | 2022-12-22 |
| AU2020349002A1 (en) | 2022-04-28 |
| JP7762648B2 (ja) | 2025-10-30 |
| CN114728088A (zh) | 2022-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP1673498S (ja) | バックパック | |
| IL284061A (en) | Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound | |
| IL290447A (en) | Pharmaeutical composition comprising ensifentrine | |
| HUE055762T2 (hu) | Nyújtott hatású készítmények | |
| HUE061610T2 (hu) | Készítmény | |
| SI4545100T1 (sl) | Stabilne, koncentrirane kompleksne raztopine radionuklidov | |
| EP4241729A4 (en) | DENTAL PROSTHESIS ATTACHMENT | |
| PL3709970T3 (pl) | Preparaty linezolidu | |
| EP3949847A4 (en) | CLOTHING | |
| EP3733179A4 (en) | PHARMACEUTICAL PREPARATION CONTAINING A PYRIDYLAMINOACETIC ACID COMPOUND | |
| IL281170A (en) | An iron containing composition and use thereof | |
| HUE067640T2 (hu) | Gyûrûs rögzítõ | |
| HUE061195T2 (hu) | Agrokémiai készítmény | |
| SI3996688T1 (sl) | Farmacevtski preparat | |
| EP3921563C0 (en) | ASSEMBLY FOR INFUSION | |
| UA42803S (uk) | Рюкзак | |
| UA41724S (uk) | Рюкзак | |
| UA41865S (uk) | Рюкзак | |
| UA41863S (uk) | Рюкзак | |
| UA41864S (uk) | Рюкзак | |
| UA41862S (uk) | Рюкзак | |
| ES1232839Y (es) | Maqueta tiflológica sensor-táctil | |
| TH191177S (th) | ของเล่น | |
| ES1237101Y (es) | Juguete | |
| EP3674569C0 (en) | CONNECTION CLIP |